Flagellin stimulates protective lung mucosal immunity: Role of cathelicidin-related antimicrobial peptide

Journal of Immunology

Volumn 185, Issue 2, 2010, Pages 1142-1149

  Yu, Fu Shin ^a   Cornicelli, Matthew D ^b   Kovach, Melissa A ^b   Newstead, Michael W ^b   Zeng, Xianying ^b   Kumar, Ashok ^a   Gao, Nan ^a   Yoon, Sang Gi ^a   Gallo, Richard L ^c   Standiford, Theodore J ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN RELATED ANTIMICROBIAL PEPTIDE; FLAGELLIN; POLYPEPTIDE ANTIBIOTIC AGENT; TOLL LIKE RECEPTOR 5; UNCLASSIFIED DRUG; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE; PSEUDOMONAS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; INNATE IMMUNITY; LETHALITY; LEUKOCYTE; LUNG ALVEOLUS; LUNG ALVEOLUS MACROPHAGE; LUNG CLEARANCE; MALE; MOUSE; MUCOSAL IMMUNITY; NEUTROPHIL; NONHUMAN; PERMEABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PNEUMONIA; RESPIRATORY TRACT MUCOSA; SURVIVAL; ANIMAL; BACTERIAL PNEUMONIA; C57BL MOUSE; CELL CULTURE; DRUG EFFECT; EPITHELIUM CELL; GENE EXPRESSION; GENETICS; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; LUNG; MACROPHAGE; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; NUDE MOUSE; PSEUDOMONAS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADMINISTRATION, INTRANASAL; ANIMALS; BLOTTING, WESTERN; CATHELICIDINS; CELLS, CULTURED; EPITHELIAL CELLS; FEMALE; FLAGELLIN; GENE EXPRESSION; IMMUNITY, MUCOSAL; LEUKOCYTES; LUNG; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, NUDE; PNEUMONIA, BACTERIAL; PSEUDOMONAS INFECTIONS; PSEUDOMONAS VACCINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; TOLL-LIKE RECEPTOR 5;

EID: 77955494032     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000509     Document Type: Article

References (50)

1. Pier, G., and R. Ramphal. 2004. Principles and Practice of Infectious Diseases. Elsevier Press, New York.
2. Hauser, A. R., E. Cobb, M. Bodi, D. Mariscal, J. Vallés, J. N. Engel, and J. Rello. 2002. Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit. Care Med. 30: 521-528.
3. Rello, J., D. A. Ollendorf, G. Oster, M. Vera-Llonch, L. Bellm, R. Redman, and M. H. Kollef; VAP Outcomes Scientific Advisory Group. 2002. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 122: 2115-2121.
4. Sawa, T., D. B. Corry, M. A. Gropper, M. Ohara, K. Kurahashi, and J. P. Wiener- Kronish. 1997. IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia. J. Immunol. 159: 2858-2866.
5. Faure, K., T. Sawa, T. Ajayi, J. Fujimoto, K. Moriyama, N. Shime, and J. P. Wiener-Kronish. 2004. TLR4 signaling is essential for survival in acute lung injury induced by virulent Pseudomonas aeruginosa secreting type III secretory toxins. Respir. Res. 5: 1.
6. An, H., Y. Yu, M. Zhang, H. Xu, R. Qi, X. Yan, S. Liu, W. Wang, Z. Guo, J. Guo, et al. 2002. Involvement of ERK, p38 and NF-kappaB signal transduction in regulation of TLR2, TLR4 and TLR9 gene expression induced by lipopolysaccharide in mouse dendritic cells. Immunology 106: 38-45. (Pubitemid 34437875)
7. Aderem, A., and R. J. Ulevitch. 2000. Toll-like receptors in the induction of the innate immune response. Nature 406: 782-787.
8. Akira, S., and H. Hemmi. 2003. Recognition of pathogen-associated molecular patterns by TLR family. Immunol. Lett. 85: 85-95.
9. Harshey, R. M., and A. Toguchi. 1996. Spinning tails: homologies among bacterial flagellar systems. Trends Microbiol. 4: 226-231.
10. Andersen-Nissen, E., K. D. Smith, R. Bonneau, R. K. Strong, and A. Aderem. 2007. A conserved surface on Toll-like receptor 5 recognizes bacterial flagellin. J. Exp. Med. 204: 393-403.
11. Feuillet, V., S. Medjane, I. Mondor, O. Demaria, P. P. Pagni, J. E. Galán, R. A. Flavell, and L. Alexopoulou. 2006. Involvement of Toll-like receptor 5 in the recognition of flagellated bacteria. Proc. Natl. Acad. Sci. USA 103: 12487-12492.
12. Gewirtz, A. T., T. A. Navas, S. Lyons, P. J. Godowski, and J. L. Madara. 2001. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J. Immunol. 167: 1882-1885.
13. Hayashi, F., K. D. Smith, A. Ozinsky, T. R. Hawn, E. C. Yi, D. R. Goodlett, J. K. Eng, S. Akira, D. M. Underhill, and A. Aderem. 2001. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410: 1099-1103. (Pubitemid 32391041)
14. Sebastiani, G., G. Leveque, L. Larivière, L. Laroche, E. Skamene, P. Gros, and D. Malo. 2000. Cloning and characterization of the murine toll-like receptor 5 (Tlr5) gene: sequence and mRNA expression studies in Salmonella-susceptible MOLF/Ei mice. Genomics 64: 230-240. (Pubitemid 30212624)
15. Adamo, R., S. Sokol, G. Soong, M. I. Gomez, and A. Prince. 2004. Pseudomonas aeruginosa flagella activate airway epithelial cells through asialoGM1 and toll-like receptor 2 as well as toll-like receptor 5. Am. J. Respir. Cell Mol. Biol. 30: 627-634.
16. Franchi, L., J. Stoolman, T. D. Kanneganti, A. Verma, R. Ramphal, and G. Núñez. 2007. Critical role for Ipaf in Pseudomonas aeruginosa-induced caspase-1 activation. Eur. J. Immunol. 37: 3030-3039.
17. Skerrett, S. J., C. B. Wilson, H. D. Liggitt, and A. M. Hajjar. 2007. Redundant Toll-like receptor signaling in the pulmonary host response to Pseudomonas aeruginosa. Am. J. Physiol. Lung Cell. Mol. Physiol. 292: L312-L322.
18. Vijay-Kumar, M., J. D. Aitken, C. J. Sanders, A. Frias, V. M. Sloane, J. Xu, A. S. Neish, M. Rojas, and A. T. Gewirtz. 2008. Flagellin treatment protects against chemicals, bacteria, viruses, and radiation. J. Immunol. 180: 8280-8285.
19. Kumar, A., L. D. Hazlett, and F. S. Yu. 2008. Flagellin suppresses the inflammatory response and enhances bacterial clearance in a murine model of Pseudomonas aeruginosa keratitis. Infect. Immun. 76: 89-96.
20. Kumar, A., J. Yin, J. Zhang, and F. S. Yu. 2007. Modulation of corneal epithelial innate immune response to pseudomonas infection by flagellin pretreatment. Invest. Ophthalmol. Vis. Sci. 48: 4664-4670.
21. Ramphal, R., V. Balloy, J. Jyot, A. Verma, M. Si-Tahar, and M. Chignard. 2008. Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin. J. Immunol. 181: 586-592.
22. Vijay-Kumar, M., H. Wu, R. Jones, G. Grant, B. Babbin, T. P. King, D. Kelly, A. T. Gewirtz, and A. S. Neish. 2006. Flagellin suppresses epithelial apoptosis and limits disease during enteric infection. Am. J. Pathol. 169: 1686-1700.
23. Ganz, T., and R. I. Lehrer. 1994. Defensins. Curr. Opin. Immunol. 6: 584-589.
24. Bals, R., and J. M. Wilson. 2003. Cathelicidins - a family of multifunctional antimicrobial peptides. Cell. Mol. Life Sci. 60: 711-720.
25. Zanetti, M., R. Gennaro, and D. Romeo. 1995. Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett. 374: 1-5.
26. Agerberth, B., H. Gunne, J. Odeberg, P. Kogner, H. G. Boman, and G. H. Gudmundsson. 1995. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc. Natl. Acad. Sci. USA 92: 195-199.
27. Gudmundsson, G. H., B. Agerberth, J. Odeberg, T. Bergman, B. Olsson, and R. Salcedo. 1996. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur. J. Biochem. 238: 325-332.
28. Pestonjamasp, V. K., K. H. Huttner, and R. L. Gallo. 2001. Processing site and gene structure for the murine antimicrobial peptide CRAMP. Peptides 22: 1643-1650.
29. Cowland, J. B., A. H. Johnsen, and N. Borregaard. 1995. hCAP-18, a cathelin/ pro-bactenecin-like protein of human neutrophil specific granules. FEBS Lett. 368: 173-176.
30. Shaykhiev, R., C. Beisswenger, K. Kändler, J. Senske, A. Püchner, T. Damm, J. Behr, and R. Bals. 2005. Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. Am. J. Physiol. Lung Cell. Mol. Physiol. 289: L842-L848.
31. Heilborn, J. D., M. F. Nilsson, G. Kratz, G. Weber, O. Sørensen, N. Borregaard, and M. Ståhle-Bäckdahl. 2003. The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J. Invest. Dermatol. 120: 379-389.
32. Bals, R., D. J. Weiner, A. D. Moscioni, R. L. Meegalla, and J. M. Wilson. 1999. Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. Infect. Immun. 67: 6084-6089.
33. Iimura, M., R. L. Gallo, K. Hase, Y. Miyamoto, L. Eckmann, and M. F. Kagnoff. 2005. Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. J. Immunol. 174: 4901-4907.
34. -/-) mice show increased susceptibility to Pseudomonas aeruginosa keratitis. Invest. Ophthalmol. Vis. Sci. 48: 4498-4508.
35. Braff, M. H., M. Zaiou, J. Fierer, V. Nizet, and R. L. Gallo. 2005. Keratinocyte production of cathelicidin provides direct activity against bacterial skin pathogens. Infect. Immun. 73: 6771-6781.
36. Bals, R., D. J. Weiner, R. L. Meegalla, and J. M. Wilson. 1999. Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model. J. Clin. Invest. 103: 1113-1117.
37. Scott, M. G., D. J. Davidson, M. R. Gold, D. Bowdish, and R. E. Hancock. 2002. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J. Immunol. 169: 3883-3891.
38. Tjabringa, G. S., J. Aarbiou, D. K. Ninaber, J. W. Drijfhout, O. E. Sørensen, N. Borregaard, K. F. Rabe, and P. S. Hiemstra. 2003. The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J. Immunol. 171: 6690-6696.
39. Cirioni, O., A. Giacometti, R. Ghiselli, C. Bergnach, F. Orlando, C. Silvestri, F. Mocchegiani, A. Licci, B. Skerlavaj, M. Rocchi, et al. 2006. LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. Antimicrob. Agents Chemother. 50: 1672-1679.
40. Tsai, W. C., R. M. Strieter, B. Mehrad, M. W. Newstead, X. Zeng, and T. J. Standiford. 2000. CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia. Infect. Immun. 68: 4289-4296.
41. Nizet, V., T. Ohtake, X. Lauth, J. Trowbridge, J. Rudisill, R. A. Dorschner, V. Pestonjamasp, J. Piraino, K. Huttner, and R. L. Gallo. 2001. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414: 454-457.
42. Moore, B. B., M. Peters-Golden, P. J. Christensen, V. Lama, W. A. Kuziel, R. Paine, III, and G. B. Toews. 2003. Alveolar epithelial cell inhibition of fibroblast proliferation is regulated by MCP-1/CCR2 and mediated by PGE2. Am. J. Physiol. Lung Cell. Mol. Physiol. 284: L342-L349.
43. Deng, J. C., G. Cheng, M. W. Newstead, X. Zeng, K. Kobayashi, R. A. Flavell, and T. J. Standiford. 2006. Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M. J. Clin. Invest. 116: 2532-2542.
44. Horowitz, A. D., B. Moussavian, E. D. Han, J. E. Baatz, and J. A. Whitsett. 1997. Distinct effects of SP-A and SP-B on endocytosis of SP-C by pulmonary epithelial cells. Am. J. Physiol. 273: L159-L171.
45. Travis, S. M., N. N. Anderson, W. R. Forsyth, C. Espiritu, B. D. Conway, E. P. Greenberg, P. B. McCray, Jr., R. I. Lehrer, M. J. Welsh, and B. F. Tack. 2000. Bactericidal activity of mammalian cathelicidin-derived peptides. Infect. Immun. 68: 2748-2755.
46. Bals, R., X. Wang, M. Zasloff, and J. M. Wilson. 1998. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl. Acad. Sci. USA 95: 9541-9546.
47. Rivas-Santiago, B., R. Hernandez-Pando, C. Carranza, E. Juarez, J. L. Contreras, D. Aguilar-Leon, M. Torres, and E. Sada. 2008. Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells. Infect. Immun. 76: 935-941.
48. Koczulla, R., G. von Degenfeld, C. Kupatt, F. Krötz, S. Zahler, T. Gloe, K. Issbrücker, P. Unterberger, M. Zaiou, C. Lebherz, et al. 2003. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J. Clin. Invest. 111: 1665-1672.
49. Felgentreff, K., C. Beisswenger, M. Griese, T. Gulder, G. Bringmann, and R. Bals. 2006. The antimicrobial peptide cathelicidin interacts with airway mucus. Peptides 27: 3100-3106. (Pubitemid 44738164)
50. Weiner, D. J., R. Bucki, and P. A. Janmey. 2003. The antimicrobial activity of the cathelicidin LL37 is inhibited by F-actin bundles and restored by gelsolin. Am. J. Respir. Cell Mol. Biol. 28: 738-745.